Regulation and function of the RSK family of protein kinases

Biochemical Journal

Volumn 441, Issue 2, 2012, Pages 553-569

  Romeo, Yves ^a   Zhang, Xiaocui ^a   Roux, Philippe P ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

90 kDa ribosomal S6 kinase (RSK); Cell signalling; Mitogen activated protein kinase (MAPK); Phosphorylation; Proliferation; Protein kinase

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BID 1870; ISOPROTEIN; PHOSPHOTRANSFERASE INHIBITOR; S6 KINASE; SL 0101; UNCLASSIFIED DRUG;

CELL CYCLE PROGRESSION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE CHECKPOINTS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SEQUENCE ALIGNMENT;

CAENORHABDITIS ELEGANS; VERTEBRATA;

EID: 84555189440     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20110289     Document Type: Review

References (189)

1. Meloche, S. and Pouyssegur, J. (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26, 3227-3239 (Pubitemid 46763017)
2. Yoon, S. and Seger, R. (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24, 21-44 (Pubitemid 43108774)
3. Rubinfeld, H. and Seger, R. (2005) The ERK cascade: a prototype of MAPK signaling. Mol. Biotechnol. 31, 151-174 (Pubitemid 41306584)
4. Roux, P. P. and Blenis, J. (2007) MAPK signaling in human diseases. In Apoptosis, Cell Signaling, and Human Diseases: Molecular Mechanisms (Srivastava, R., ed.), pp. 135-149, Humana Press, Totowa
5. E600 in benign and malignant human tumours. Oncogene 27, 877-895
6. Dhomen, N. and Marais, R. (2007) New insight into BRAF mutations in cancer. Curr. Opin. Genet. Dev. 17, 31-39 (Pubitemid 46109299)
7. Roux, P. P. and Blenis, J. (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68, 320-344 (Pubitemid 38756868)
8. Cargnello, M. and Roux, P. P. (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol. Mol. Biol. Rev. 75, 50-83
9. Arthur, J. S. (2008) MSK activation and physiological roles. Front. Biosci. 13, 5866-5879
10. Vermeulen, L., Berghe, W. V., Beck, I. M., De Bosscher, K. and Haegeman, G. (2009) The versatile role of MSKs in transcriptional regulation. Trends Biochem. Sci. 34, 311-318
11. Gressner, A. M. and Wool, I. G. (1974) The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J. Biol. Chem. 249, 6917-6925
12. Meyuhas, O. (2008) Physiological roles of ribosomal protein S6: one of its kind. Int. Rev. Cell Mol. Biol. 268, 1-37
13. Blenis, J. and Erikson, R. L. (1984) Phosphorylation of the ribosomal protein S6 is elevated in cells transformed by a variety of tumor viruses. J. Virol. 50, 966-969 (Pubitemid 14105621)
14. Nielsen, P. J., Thomas, G. and Maller, J. L. (1982) Increased phosphorylation of ribosomal protein S6 during meiotic maturation of Xenopus oocytes. Proc. Natl. Acad. Sci. U.S.A. 79, 2937-2941 (Pubitemid 12032346)
15. Erikson, E. and Maller, J. L. (1985) A protein kinase from Xenopus eggs specific for ribosomal protein S6. Proc. Natl. Acad. Sci. U.S.A. 82, 742-746 (Pubitemid 15142754)
16. Jones, S. W., Erikson, E., Blenis, J., Maller, J. L. and Erikson, R. L. (1988) A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases. Proc. Natl. Acad. Sci. U.S.A. 85, 3377-3381
17. Sturgill, T. W., Ray, L. B., Erikson, E. and Maller, J. L. (1988) Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334, 715-718
18. Erikson, E. and Maller, J. L. (1986) Purification and characterization of a protein kinase from Xenopus eggs highly specific for ribosomal protein S6. J. Biol. Chem. 261, 350-355 (Pubitemid 16103952)
19. rsk and pp70-S6 kinase signaling systems are indicated by inhibition of protein synthesis. Cell Growth Differ. 2, 279-285
20. Chung, J., Kuo, C. J., Crabtree, G. R. and Blenis, J. (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69, 1227-1236
21. Kuo, C. J., Chung, J., Fiorentino, D. F., Flanagan, W. M., Blenis, J. and Crabtree, G. R. (1992) Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358, 70-73
22. -/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell. Biol. 24, 3112-3124
23. Roux, P. P., Shahbazian, D., Vu, H., Holz, M. K., Cohen, M. S., Taunton, J., Sonenberg, N. and Blenis, J. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J. Biol. Chem. 282, 14056-14064 (Pubitemid 47100467)
24. Roux, P. P. (2007) Rsk1. UCSD Nature Molecule Pages, doi:10.1038/mp. a002099.002001
25. Julien, L.-A. and Roux, P. P. (2007) Rsk3. UCSD Nature Molecule Pages, doi:10.1038/mp.a002101.002101
26. Roux, P. P. (2007) Rsk4. UCSD Nature Molecule Pages, doi:10.1038/mp. a002102.002101
27. Fisher, T. L. and Blenis, J. (1996) Evidence for two catalytically active kinase domains in pp90rsk. Mol. Cell. Biol. 16, 1212-1219
28. Buxade, M., Parra-Palau, J. L. and Proud, C. G. (2008) The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases). Front. Biosci. 13, 5359-5373
29. Ronkina, N., Kotlyarov, A. and Gaestel, M. (2008) MK2 and MK3 - a pair of isoenzymes? Front. Biosci. 13, 5511-5521
30. Perander, M., Keyse, S. M. and Seternes, O. M. (2008) Does MK5 reconcile classical and atypical MAP kinases? Front. Biosci. 13, 4617-4624 (Pubitemid 351589186)
31. rskkinase domains. J. Biol. Chem. 270, 18848-18852
32. Vik, T. A. and Ryder, J. W. (1997) Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk. Biochem. Biophys. Res. Commun. 235, 398-402 (Pubitemid 27313719)
33. Chrestensen, C. A. and Sturgill, T. W. (2002) Characterization of the p90 ribosomal S6 kinase 2 carboxyl-terminal domain as a protein kinase. J. Biol. Chem. 277, 27733-27741 (Pubitemid 34966717)
34. Tanoue, T. and Nishida, E. (2003) Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15, 455-462 (Pubitemid 36287667)
35. MacKenzie, S. J., Baillie, G. S., McPhee, I., Bolger, G. B. and Houslay, M. D. (2000) ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J. Biol. Chem. 275, 16609-16617 (Pubitemid 30398887)
36. Pulido, R., Zuniga, A. and Ullrich, A. (1998) PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17, 7337-7350 (Pubitemid 29002702)
37. Smith, J. A., Poteet-Smith, C. E., Malarkey, K. and Sturgill, T. W. (1999) Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274, 2893-2898 (Pubitemid 29075375)
38. rsk/MAPKAP kinase-1. Curr. Biol. 9, 281-284
39. Roux, P. P., Richards, S. A. and Blenis, J. (2003) Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23, 4796-4804 (Pubitemid 36793327)
40. Thomas, G. M., Rumbaugh, G. R., Harrar, D. B. and Huganir, R. L. (2005) Ribosomal S6 kinase 2 interacts with and phosphorylates PDZ domain-containing proteins and regulates AMPA receptor transmission. Proc. Natl. Acad. Sci. U.S.A. 102, 15006-15011 (Pubitemid 41513325)
41. Zeniou, M., Ding, T., Trivier, E. and Hanauer, A. (2002) Expression analysis of RSK gene family members: the RSK2 gene, mutated in Coffin-Lowry syndrome, is prominently expressed in brain structures essential for cognitive function and learning. Hum. Mol. Genet. 11, 2929-2940
42. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J., Huss, III, J. W. and Su, A. I. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130
43. Alcorta, D. A., Crews, C. M., Sweet, L. J., Bankston, L., Jones, S. W. and Erikson, R. L. (1989) Sequence and expression of chicken and mouse rsk: homologs of Xenopus laevis ribosomal S6 kinase. Mol. Cell. Biol. 9, 3850-3859 (Pubitemid 19216278)
44. Moller, D. E., Xia, C. H., Tang, W., Zhu, A. X. and Jakubowski, M. (1994) Human rsk isoforms: cloning and characterization of tissue-specific expression. Am. J. Physiol. 266, 351-359
45. Heffron, D. and Mandell, J. W. (2005) Differential localization of MAPK-activated protein kinases RSK1 and MSK1 in mouse brain. Brain Res. Mol. Brain Res. 136, 134-141 (Pubitemid 40704616)
46. Dummler, B. A., Hauge, C., Silber, J., Yntema, H. G., Kruse, L. S., Kofoed, B., Hemmings, B. A., Alessi, D. R. and Frodin, M. (2005) Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J. Biol. Chem. 280, 13304-13314 (Pubitemid 40517216)
47. Kohn, M., Hameister, H., Vogel, M. and Kehrer-Sawatzki, H. (2003) Expression pattern of the Rsk2, Rsk4 and Pdk1 genes during murine embryogenesis. Gene Expr. Patterns 3, 173-177 (Pubitemid 36511306)
48. Yntema, H. G., van den Helm, B., Kissing, J., van Duijnhoven, G., Poppelaars, F., Chelly, J., Moraine, C., Fryns, J. P., Hamel, B. C., Heilbronner, H. et al. (1999) A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 62, 332-343 (Pubitemid 30075162)
49. Chen, R. H., Sarnecki, C. and Blenis, J. (1992) Nuclear localization and regulation of erk - and rsk -encoded protein kinases. Mol. Cell. Biol. 12, 915-927
50. mapkk) in fibroblasts. J. Cell Biol. 122, 1079-1088
51. rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol. Cell. Biol. 15, 4353-4363
52. Richards, S. A., Dreisbach, V. C., Murphy, L. O. and Blenis, J. (2001) Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1. Mol. Cell. Biol. 21, 7470-7480 (Pubitemid 32953497)
53. Vaidyanathan, H. and Ramos, J. W. (2003) RSK2 activity is regulated by its interaction with PEA-15. J. Biol. Chem. 278, 32367-32372 (Pubitemid 37048433)
54. Eisinger-Mathason, T. S., Andrade, J., Groehler, A. L., Clark, D. E., Muratore-Schroeder, T. L., Pasic, L., Smith, J. A., Shabanowitz, J., Hunt, D. F., Macara, I. G. and Lannigan, D. A. (2008) Codependent functions of RSK2 and the apoptosis-promoting factor TIA-1 in stress granule assembly and cell survival. Mol. Cell 31, 722-736
55. Dalby, K. N., Morrice, N., Caudwell, F. B., Avruch, J. and Cohen, P. (1998) Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)- activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273, 1496-1505 (Pubitemid 28133672)
56. Jensen, C. J., Buch, M. B., Krag, T. O., Hemmings, B. A., Gammeltoft, S. and Frodin, M. (1999) 90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J Biol. Chem. 274, 27168-27176
57. Richards, S. A., Fu, J., Romanelli, A., Shimamura, A. and Blenis, J. (1999) Ribosomal S6 kinase 1 (RSK1) activation requires signals dependent on and independent of the MAP kinase ERK. Curr. Biol. 9, 810-820 (Pubitemid 29375183)
58. Mora, A., Komander, D., van Aalten, D. M. and Alessi, D. R. (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15, 161-170 (Pubitemid 38251644)
59. Williams, M. R., Arthur, J. S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P. and Alessi, D. R. (2000) The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448 (Pubitemid 30247331)
60. 3 binding to PDK1 PH domain defined by knockin mutation. EMBO J. 23, 2071-2082
61. Newton, A. C. (2003) Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370, 361-371
62. Frodin, M., Jensen, C. J., Merienne, K. and Gammeltoft, S. (2000) A phosphoserineregulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J. 19, 2924-2934 (Pubitemid 30386764)
63. Frodin, M., Antal, T. L., Dummler, B. A., Jensen, C. J., Deak, M., Gammeltoft, S. and Biondi, R. M. (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21, 5396-5407 (Pubitemid 35231019)
64. Sutherland, C., Alterio, J., Campbell, D. G., Le Bourdelles, B., Mallet, J., Haavik, J. and Cohen, P. (1993) Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur. J. Biochem. 217, 715-722 (Pubitemid 23311985)
65. Sutherland, C., Campbell, D. G. and Cohen, P. (1993) Identification of insulin-stimulated protein kinase-1 as the rabbit equivalent of rskmo-2: identification of two threonines phosphorylated during activation by mitogen-activated protein kinase. Eur. J. Biochem. 212, 581-588 (Pubitemid 23076128)
66. Ranganathan, A., Pearson, G. W., Chrestensen, C. A., Sturgill, T. W. and Cobb, M. H. (2006) The MAP kinase ERK5 binds to and phosphorylates p90 RSK. Arch. Biochem. Biophys. 449, 8-16
67. Kang, S., Dong, S., Gu, T. L., Guo, A., Cohen, M. S., Lonial, S., Khoury, H. J., Fabbro, D., Gilliland, D. G., Bergsagel, P. L. et al. (2007) FGFR3 Activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway. Cancer Cell 12, 201-214 (Pubitemid 47333416)
68. Kang, S., Dong, S., Guo, A., Ruan, H., Lonial, S., Khoury, H. J., Gu, T. L. and Chen, J. (2008) Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529. J. Biol. Chem. 283, 4652-4657
69. Cohen, M. S., Hadjivassiliou, H. and Taunton, J. (2007) A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nat. Chem. Biol. 3, 156-160
70. Zaru, R., Ronkina, N., Gaestel, M., Arthur, J. S. and Watts, C. (2007) The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is activated through two distinct pathways. Nat. Immunol. 8, 1227-1235 (Pubitemid 350011762)
71. Chaturvedi, D., Poppleton, H. M., Stringfield, T., Barbier, A. and Patel, T. B. (2006) Subcellular localization and biological actions of activated RSK1 are determined by its interactions with subunits of cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 26, 4586-4600 (Pubitemid 43877577)
72. Chaturvedi, D., Cohen, M. S., Taunton, J. and Patel, T. B. (2009) The PKARIá subunit of protein kinase A modulates the activation of p90RSK1 and its function. J. Biol. Chem. 284, 23670-23681
73. Doehn, U., Gammeltoft, S., Shen, S. H. and Jensen, C. J. (2004) p90 ribosomal S6 kinase 2 is associated with and dephosphorylated by protein phosphatase 2Cδ. Biochem. J. 382, 425-431 (Pubitemid 39243908)
74. Nguyen, T. L. (2008) Targeting RSK: an overview of small molecule inhibitors. Anticancer Agents Med. Chem. 8, 710-716
75. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
76. Sapkota, G. P., Cummings, L., Newell, F. S., Armstrong, C., Bain, J., Frodin, M., Grauert, M., Hoffmann, M., Schnapp, G., Steegmaier, M. et al. (2007) BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo. Biochem. J. 401, 29-38 (Pubitemid 46114597)
77. Smith, J. A., Poteet-Smith, C. E., Xu, Y., Errington, T. M., Hecht, S. M. and Lannigan, D. A. (2005) Identification of the first specific inhibitor of p90 ribosomal S6 kinase (RSK) reveals an unexpected role for RSK in cancer cell proliferation. Cancer Res. 65, 1027-1034 (Pubitemid 40216465)
78. Cohen, M. S., Zhang, C., Shokat, K. M. and Taunton, J. (2005) Structural bioinformatics-based design of selective, irreversible kinase inhibitors. Science 308, 1318-1321 (Pubitemid 40746129)
79. Leighton, I. A., Dalby, K. N., Caudwell, F. B., Cohen, P. T. and Cohen, P. (1995) Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett. 375, 289-293
80. Doehn, U., Hauge, C., Frank, S. R., Jensen, C. J., Duda, K., Nielsen, J. V., Cohen, M. S., Johansen, J. V., Winther, B. R., Lund, L. R. et al. (2009) RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol. Cell 35, 511-522
81. Bruning, J. C., Gillette, J. A., Zhao, Y., Bjorbaeck, C., Kotzka, J., Knebel, B., Avci, H., Hanstein, B., Lingohr, P., Moller, D. E. et al. (2000) Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene. Proc. Natl. Acad. Sci. U.S.A. 97, 2462-2467 (Pubitemid 30159193)
82. De Cesare, D., Jacquot, S., Hanauer, A. and Sassone-Corsi, P. (1998) Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc. Natl. Acad. Sci. U.S.A. 95, 12202-12207 (Pubitemid 28483743)
83. Ginty, D. D., Bonni, A. and Greenberg, M. E. (1994) Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77, 713-725 (Pubitemid 24175607)
84. Xing, J., Ginty, D. D. and Greenberg, M. E. (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273, 959-963 (Pubitemid 26275173)
85. Wiggin, G. R., Soloaga, A., Foster, J. M., Murray-Tait, V., Cohen, P. and Arthur, J. S. (2002) MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22, 2871-2881 (Pubitemid 34263007)
86. Soloaga, A., Thomson, S., Wiggin, G. R., Rampersaud, N., Dyson, M. H., Hazzalin, C. A., Mahadevan, L. C. and Arthur, J. S. (2003) MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788-2797 (Pubitemid 36712374)
87. Rivera, V. M., Miranti, C. K., Misra, R. P., Ginty, D. D., Chen, R. H., Blenis, J. and Greenberg, M. E. (1993) A growth factor-induced kinase phosphorylates the serum response factor at a site that regulates its DNA-binding activity. Mol. Cell. Biol. 13, 6260-6273 (Pubitemid 23292620)
88. Chen, R. H., Abate, C. and Blenis, J. (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 90, 10952-10956 (Pubitemid 23354346)
89. Davis, I. J., Hazel, T. G., Chen, R. H., Blenis, J. and Lau, L. F. (1993) Functional domains and phosphorylation of the orphan receptor Nur77. Mol. Endocrinol. 7, 953-964 (Pubitemid 23252334)
90. Wingate, A. D., Campbell, D. G., Peggie, M. and Arthur, J. S. (2006) Nur77 is phosphorylated in cells by RSK in response to mitogenic stimulation. Biochem. J. 393, 715-724 (Pubitemid 43163811)
91. David, J. P., Mehic, D., Bakiri, L., Schilling, A. F., Mandic, V., Priemel, M., Idarraga, M. H., Reschke, M. O., Hoffmann, O., Amling, M. and Wagner, E. F. (2005) Essential role of RSK2 in c-Fos-dependent osteosarcoma development. J. Clin. Invest. 115, 664-672 (Pubitemid 40322240)
92. Bakiri, L., Reschke, M. O., Gefroh, H. A., Idarraga, M. H., Polzer, K., Zenz, R., Schett, G. and Wagner, E. F. (2011) Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis. Oncogene 30, 1506-1517
93. Zhao, J., Yuan, X., Frodin, M. and Grummt, I. (2003) ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Mol. Cell 11, 405-413 (Pubitemid 36293834)
94. rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167. Mol. Cell. Biol. 18, 1978-1984
95. Yamnik, R. L. and Holz, M. K. (2010) mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor á serine 167 phosphorylation. FEBS Lett. 584, 124-128
96. Wu, J. and Janknecht, R. (2002) Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J. Biol. Chem. 277, 42669-42679 (Pubitemid 35285636)
97. Wu, M., Hemesath, T. J., Takemoto, C. M., Horstmann, M. A., Wells, A. G., Price, E. R., Fisher, D. Z. and Fisher, D. E. (2000) c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 14, 301-312 (Pubitemid 30106485)
98. Park, H. Y. and Gilchrest, B. A. (2002) More on MITF. J. Invest. Dermatol. 119, 1218-1219
99. Schouten, G. J., Vertegaal, A. C. O., Whiteside, S. T., Israel, A., Toebes, M., Dorsman, J. C., van der Eb, A. J. and Zantema, A. (1997) IκBα is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16, 3133-3144 (Pubitemid 27234953)
100. Ghoda, L., Lin, X. and Greene, W. C. (1997) The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J. Biol. Chem. 272, 21281-21288 (Pubitemid 27373994)
101. Xu, S., Bayat, H., Hou, X. and Jiang, B. (2006) Ribosomal S6 kinase-1 modulates interleukin-1β-induced persistent activation of NF-κB through phosphorylation of IκBβ. Am. J. Physiol. Cell Physiol. 291, C1336-C1345 (Pubitemid 44878605)
102. Bohuslav, J., Chen, L. F., Kwon, H., Mu, Y. and Greene, W. C. (2004) p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J. Biol. Chem. 279, 26115-26125 (Pubitemid 38798756)
103. Zhang, L., Ma, Y., Zhang, J., Cheng, J. and Du, J. (2005) A new cellular signaling mechanism for angiotensin II activation of NF-κB: an IκB-independent, RSK-mediated phosphorylation of p65. Arterioscler. Thromb. Vasc. Biol. 25, 1148-1153 (Pubitemid 40776601)
104. Douillette, A., Bibeau-Poirier, A., Gravel, S. P., Clement, J. F., Chenard, V., Moreau, P. and Servant, M. J. (2006) The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IκB kinase complex. J. Biol. Chem. 281, 13275-13284 (Pubitemid 43855239)
105. Nakajima, T., Fukamizu, A., Takahashi, J., Gage, F. H., Fisher, T., Blenis, J. and Montminy, M. R. (1996) The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 86, 465-474 (Pubitemid 26272086)
106. Wang, Z., Zhang, B., Wang, M. and Carr, B. I. (2003) Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK. J. Biol. Chem. 278, 11138-11144 (Pubitemid 36792667)
107. Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone-Corsi, P., Townes, T. M. et al. (2004) ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-398 (Pubitemid 38534544)
108. Clark, D. E., Errington, T. M., Smith, J. A., Frierson, Jr, H. F., Weber, M. J. and Lannigan, D. A. (2005) The serine/threonine protein kinase, p90 ribosomal s6 kinase, is an important regulator of prostate cancer cell proliferation. Cancer Res. 65, 3108-3116 (Pubitemid 40524591)
109. Chen, R. H., Juo, P. C., Curran, T. and Blenis, J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12, 1493-1502 (Pubitemid 26132036)
110. Murphy, L. O., Smith, S., Chen, R. H., Fingar, D. C. and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564
111. Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 278, 49254-49260
112. Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc. Natl. Acad. Sci. U.S.A. 106, 9268-9273
113. Sutherland, C., Leighton, I. A. and Cohen, P. (1993) Inactivation of glycogen synthase kinase-3 β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296, 15-19 (Pubitemid 23344723)
114. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776 (Pubitemid 33679839)
115. Zhu, J., Blenis, J. and Yuan, J. (2008) Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proc. Natl. Acad. Sci. U.S.A. 105, 6584-6589 (Pubitemid 351754550)
116. Vigneron, S., Brioudes, E., Burgess, A., Labbe, J. C., Lorca, T. and Castro, A. (2010) RSK2 is a kinetochore-associated protein that participates in the spindle assembly checkpoint. Oncogene 29, 3566-3574
117. 433, is essential for LKB1 to suppress cell growth. J. Biol. Chem. 276, 19469-19482
118. Zheng, B., Jeong, J. H., Asara, J. M., Yuan, Y. Y., Granter, S. R., Chin, L. and Cantley, L. C. (2009) Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation. Mol. Cell 33, 237-247
119. Bhatt, R. R. and Ferrell, Jr, J. E. (2000) Cloning and characterization of Xenopus Rsk2, the predominant p90 Rsk isozyme in oocytes and eggs. J. Biol. Chem. 275, 32983-32990
120. Schmitt, A. and Nebreda, A. R. (2002) Signalling pathways in oocyte meiotic maturation. J. Cell Sci. 115, 2457-2459 (Pubitemid 34778062)
121. cdc2 inhibitory kinase Myt1. EMBO J. 17, 5037-5047
122. 2/M transition in Xenopus oocytes. J. Biol. Chem. 276, 46099-46103
123. Ruiz, E. J., Vilar, M. and Nebreda, A. R. (2010) A two-step inactivation mechanism of Myt1 ensures CDK1/cyclin B activation and meiosis I entry. Curr. Biol. 20, 717-723
124. Wang, R., Jung, S. Y., Wu, C. F., Qin, J., Kobayashi, R., Gallick, G. E. and Kuang, J. (2010) Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation. Proc. Natl. Acad. Sci. U.S.A. 107, 19885-19890
125. Bhatt, R. R. and Ferrell, Jr, J. E. (1999) The protein kinase p90 rsk as an essential mediator of cytostatic factor activity. Science 286, 1362-1365
126. Rsk. Science 286, 1365-1367
127. Rsk during Xenopus oocyte maturation. Curr. Biol. 11, 141-150
128. Tunquist, B. J., Schwab, M. S., Chen, L. G. and Maller, J. L. (2002) The spindle checkpoint kinase Bub1 and cyclin E/Cdk2 both contribute to the establishment of meiotic metaphase arrest by cytostatic factor. Curr. Biol. 12, 1027-1033 (Pubitemid 34703335)
129. Wu, J. Q., Hansen, D. V., Guo, Y., Wang, M. Z., Tang, W., Freel, C. D., Tung, J. J., Jackson, P. K. and Kornbluth, S. (2007) Control of Emi2 activity and stability through Mos-mediated recruitment of PP2A. Proc. Natl. Acad. Sci. U.S.A. 104, 16564-16569 (Pubitemid 350211058)
130. Inoue, D., Ohe, M., Kanemori, Y., Nobui, T. and Sagata, N. (2007) A direct link of the Mos-MAPK pathway to Erp1/Emi2 in meiotic arrest of Xenopus laevis eggs. Nature 446, 1100-1104 (Pubitemid 46676048)
131. rsk is required for cytostatic factor arrest in Xenopus laevis eggs. Nature 446, 1096-1099
132. Cho, Y. Y., Yao, K., Kim, H. G., Kang, B. S., Zheng, D., Bode, A. M. and Dong, Z. (2007) Ribosomal s6 kinase 2 is a key regulator in tumor promoter induced cell transformation. Cancer Res. 67, 8104-8112 (Pubitemid 47395145)
133. Bignone, P. A., Lee, K. Y., Liu, Y., Emilion, G., Finch, J., Soosay, A. E., Charnock, F. M., Beck, S., Dunham, I., Mungall, A. J. and Ganesan, T. S. (2007) RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer. Oncogene 26, 683-700 (Pubitemid 46204248)
134. Thakur, A., Sun, Y., Bollig, A., Wu, J., Biliran, H., Banerjee, S., Sarkar, F. H. and Liao, D. J. (2008) Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin. Cancer Res. 14, 4427-4436
135. Myers, A. P., Corson, L. B., Rossant, J. and Baker, J. C. (2004) Characterization of mouse Rsk4 as an inhibitor of fibroblast growth factor-RAS-extracellular signalregulated kinase signaling. Mol. Cell. Biol. 24, 4255-4266 (Pubitemid 41070997)
136. Berns, K., Hijmans, E. M., Mullenders, J., Brummelkamp, T. R., Velds, A., Heimerikx, M., Kerkhoven, R. M., Madiredjo, M., Nijkamp, W., Weigelt, B. et al. (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437 (Pubitemid 38419689)
137. Lopez-Vicente, L., Armengol, G., Pons, B., Coch, L., Argelaguet, E., Lleonart, M., Hernandez-Losa, J., de Torres, I. and Ramon y Cajal, S. (2009) Regulation of replicative and stress-induced senescence by RSK4, which is down-regulated in human tumors. Clin. Cancer Res. 15, 4546-4553
138. rsk to polyribosomes: a possible factor regulating synaptic protein synthesis. Proc. Natl. Acad. Sci. U.S.A. 95, 15078-15083
139. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. and Pandolfi, P. P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193 (Pubitemid 40546387)
140. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P. and Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 13489-13494 (Pubitemid 39238430)
141. Rolfe, M., McLeod, L. E., Pratt, P. F. and Proud, C. G. (2005) Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem. J. 388, 973-984 (Pubitemid 40941586)
142. Carriere, A., Cargnello, M., Julien, L. A., Gao, H., Bonneil, E., Thibault, P. and Roux, P. P. (2008) Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr. Biol. 18, 1269-1277
143. 535 in the ε-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin. Biochem. J. 367, 475-481
144. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (Pubitemid 37506046)
145. Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K. et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955-968 (Pubitemid 44310775)
146. RSK1 and p70 S6 kinase. EMBO J. 20, 4370-4379
147. Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M. and Sonenberg, N. (2006) The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781-2791 (Pubitemid 43980385)
148. Shahbazian, D., Parsyan, A., Petroulakis, E., Topisirovic, I., Martineau, Y., Gibbs, B. F., Svitkin, Y. and Sonenberg, N. (2010) Control of cell survival and proliferation by mammalian eukaryotic initiation factor 4B. Mol. Cell. Biol. 30, 1478-1485
149. Kroczynska, B., Joshi, S., Eklund, E. A., Verma, A., Kotenko, S. V., Fish, E. N. and Platanias, L. C. (2011) Regulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλsignaling. J. Biol. Chem. 286, 1147-1156
150. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A. and Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcriptiondependent and -independent mechanisms. Science 286, 1358-1362
151. Zhang, L., Cheng, J., Ma, Y., Thomas, W., Zhang, J. and Du, J. (2005) Dual pathways for nuclear factor κB activation by angiotensin II in vascular smooth muscle: phosphorylation of p65 by IκB kinase and ribosomal kinase. Circ. Res. 97, 975-982 (Pubitemid 41668910)
152. Buck, M., Poli, V., Hunter, T. and Chojkier, M. (2001) C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol. Cell 8, 807-816 (Pubitemid 33030214)
153. Shimamura, A., Ballif, B. A., Richards, S. A. and Blenis, J. (2000) Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 10, 127-135 (Pubitemid 30115743)
154. Bialik, S. and Kimchi, A. (2004) DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Semin. Cancer Biol. 14, 283-294 (Pubitemid 38824589)
155. Anjum, R., Roux, P. P., Ballif, B. A., Gygi, S. P. and Blenis, J. (2005) The tumor suppressor DAP kinase is a target of RSK-mediated survival signaling. Curr. Biol. 15, 1762-1767 (Pubitemid 41415634)
156. Woo, M. S., Ohta, Y., Rabinovitz, I., Stossel, T. P. and Blenis, J. (2004) Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin a on an important regulatory site. Mol. Cell. Biol. 24, 3025-3035 (Pubitemid 38381290)
157. Vadlamudi, R. K., Li, F., Adam, L., Nguyen, D., Ohta, Y., Stossel, T. P. and Kumar, R. (2002) Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat. Cell Biol. 4, 681-690 (Pubitemid 34993704)
158. Smolen, G. A., Zhang, J., Zubrowski, M. J., Edelman, E. J., Luo, B., Yu, M., Ng, L. W., Scherber, C. M., Schott, B. J., Ramaswamy, S. et al. (2010) A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration. Genes Dev. 24, 2654-2665
159. Tanimura, S., Hashizume, J., Kurosaki, Y., Sei, K., Gotoh, A., Ohtake, R., Kawano, M., Watanabe, K. and Kohno, M. (2011) SH3P2 is a negative regulator of cell motility whose function is inhibited by ribosomal S6 kinase-mediated phosphorylation. Genes Cells 16, 514-526
160. rskin neurite outgrowth mediated by the cell adhesion molecule L1. J. Biol. Chem. 271, 18217-18223
161. Song, T., Sugimoto, K., Ihara, H., Mizutani, A., Hatano, N., Kume, K., Kambe, T., Yamaguchi, F., Tokuda, M. and Watanabe, Y. (2007) p90 RSK-1 associates with and inhibits neuronal nitric oxide synthase. Biochem. J. 401, 391-398 (Pubitemid 46166421)
162. + exchanger isoform-1. J. Biol. Chem. 274, 20206-20214
163. Yoon, S. O., Shin, S., Liu, Y., Ballif, B. A., Woo, M. S., Gygi, S. P. and Blenis, J. (2008) Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport. Mol. Cell 29, 362-375 (Pubitemid 351215938)
164. Stratford, A. L., Fry, C. J., Desilets, C., Davies, A. H., Cho, Y. Y., Li, Y., Dong, Z., Berquin, I. M., Roux, P. P. and Dunn, S. E. (2008) Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells. Breast Cancer Res. 10, R99
165. Geraghty, K. M., Chen, S., Harthill, J. E., Ibrahim, A. F., Toth, R., Morrice, N. A., Vandermoere, F., Moorhead, G. B., Hardie, D. G. and MacKintosh, C. (2007) Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochem. J. 407, 231-241 (Pubitemid 47556988)
166. Douville, E. and Downward, J. (1997) EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2. Oncogene 15, 373-383 (Pubitemid 27370986)
167. Dufresne, S. D., Bjorbaek, C., El-Haschimi, K., Zhao, Y., Aschenbach, W. G., Moller, D. E. and Goodyear, L. J. (2001) Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21, 81-87
168. Trivier, E., De Cesare, D., Jacquot, S., Pannetier, S., Zackai, E., Young, I., Mandel, J. L., Sassone-Corsi, P. and Hanauer, A. (1996) Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 384, 567-570 (Pubitemid 26415934)
169. Pereira, P. M., Schneider, A., Pannetier, S., Heron, D. and Hanauer, A. (2010) Coffin-Lowry syndrome. Eur. J. Hum. Genet. 18, 627-633
170. Kesler, S. R., Simensen, R. J., Voeller, K., Abidi, F., Stevenson, R. E., Schwartz, C. E. and Reiss, A. L. (2007) Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin-Lowry syndrome. Neurogenetics 8, 143-147 (Pubitemid 46356252)
171. Delaunoy, J., Abidi, F., Zeniou, M., Jacquot, S., Merienne, K., Pannetier, S., Schmitt, M., Schwartz, C. and Hanauer, A. (2001) Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Hum. Mutat. 17, 103-116 (Pubitemid 32120712)
172. Poirier, R., Jacquot, S., Vaillend, C., Soutthiphong, A. A., Libbey, M., Davis, S., Laroche, S., Hanauer, A., Welzl, H., Lipp, H. P. and Wolfer, D. P. (2007) Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behav. Genet. 37, 31-50 (Pubitemid 46144051)
173. Dugani, C. B., Paquin, A., Kaplan, D. R. and Miller, F. D. (2010) Coffin-Lowry syndrome: a role for RSK2 in mammalian neurogenesis. Dev. Biol. 347, 348-359
174. Putz, G., Bertolucci, F., Raabe, T., Zars, T. and Heisenberg, M. (2004) The S6KII (rsk) gene of Drosophila melanogaster differentially affects an operant and a classical learning task. J. Neurosci. 24, 9745-9751 (Pubitemid 39463555)
175. El-Haschimi, K., Dufresne, S. D., Hirshman, M. F., Flier, J. S., Goodyear, L. J. and Bjorbaek, C. (2003) Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2. Diabetes 52, 1340-1346 (Pubitemid 36666186)
176. Rsk is not involved in cytostatic factor arrest in mouse oocytes. J. Cell Biol. 169, 227-231
177. Cox, B. J., Vollmer, M., Tamplin, O., Lu, M., Biechele, S., Gertsenstein, M., van Campenhout, C., Floss, T., Kuhn, R., Wurst, W. et al. (2010) Phenotypic annotation of the mouse X chromosome. Genome Res. 20, 1154-1164
178. Moritz, A., Li, Y., Guo, A., Villen, J., Wang, Y., MacNeill, J., Kornhauser, J., Sprott, K., Zhou, J., Possemato, A. et al. (2010) Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci. Signal. 3, ra64
179. Romeo, Y. and Roux, P. P. (2011) Paving the way for targeting RSK in cancer. Expert Opin. Ther. Targets 15, 5-9
180. rsk, glycogen synthase kinase 3, and β-catenin in early Xenopus development. Mol. Cell. Biol. 19, 1427-1437
181. Ballif, B. A., Roux, P. P., Gerber, S. A., MacKeigan, J. P., Blenis, J. and Gygi, S. P. (2005) Quantitative phosphorylation profiling of the ERK/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc. Natl. Acad. Sci. U.S.A. 102, 667-672 (Pubitemid 40282723)
182. Cartlidge, R. A., Knebel, A., Peggie, M., Alexandrov, A., Phizicky, E. M. and Cohen, P. (2005) The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells. EMBO J. 24, 1696-1705 (Pubitemid 40704980)
183. Yang, T. T., Xiong, Q., Graef, I. A., Crabtree, G. R. and Chow, C. W. (2005) Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex. Mol. Cell. Biol. 25, 907-920 (Pubitemid 40165800)
184. Cho, Y. Y., Yao, K., Bode, A. M., Bergen, III, H. R., Madden, B. J., Oh, S. M., Ermakova, S., Kang, B. S., Choi, H. S., Shim, J. H. and Dong, Z. (2007) RSK2 mediates muscle cell differentiation through regulation of NFAT3. J. Biol. Chem. 282, 8380-8392 (Pubitemid 47093615)
185. Elefteriou, F., Benson, M. D., Sowa, H., Starbuck, M., Liu, X., Ron, D., Parada, L. F. and Karsenty, G. (2006) ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab. 4, 441-451 (Pubitemid 44817348)
186. Liu, K., Cho, Y. Y., Yao, K., Nadas, J., Kim, D. J., Cho, E. J., Lee, M. H., Pugliese, A., Zhang, J., Bode, A. M. and Dong, Z. (2011) Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J. Biol. Chem. 286, 2057-2066
187. Wang, Y., Liu, L. and Xia, Z. (2007) Brain-derived neurotrophic factor stimulates the transcriptional and neuroprotective activity of myocyte-enhancer factor 2C through an ERK1/2-RSK2 signaling cascade. J. Neurochem. 102, 957-966 (Pubitemid 47057305)
188. Abe, Y., Yoon, S. O., Kubota, K., Mendoza, M. C., Gygi, S. P. and Blenis, J. (2009) p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling. J. Biol. Chem. 284, 14939-14948
189. Auld, G. C., Campbell, D. G., Morrice, N. and Cohen, P. (2005) Identification of calcium-regulated heat-stable protein of 24 kDa (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL. Biochem. J. 389, 775-783 (Pubitemid 41117337)